1
|
Timmerman P, Ivanova T, Arfvidsson C, Barfield M, Bove F, Brown LD, Goodman J, McDougall S, Monk L, White S. The challenges for implementing Good Clinical Practices in the bioanalytical laboratory: a discussion paper from the European Bioanalysis Forum. Bioanalysis 2024. [PMID: 38530219 DOI: 10.4155/bio-2024-0055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/27/2024] Open
Abstract
This manuscript reports back from the discussion in the European Bioanalysis Forum community on the challenges observed when implementing Good Clinical Practices in the bioanalytical laboratory. It is not intended to challenge any regulatory requirements but to open a discussion on where the bioanalytical community sees ambiguities on implementing Good Clinical Practices or areas where expectations are either felt not being owned by Bioanalysis or where Good Clinical Practices requirements are at risk of getting contaminated with requirements originating from Good Laboratory Practices. In addition to this, the discussions focused on three additional main challenges: the informed consent withdrawal, expedited reporting of unexpected results and the risk-based approach to quality management, The European Bioanalysis Forum community is continuing discussions, but already this manuscript should help to appreciate the challenges and to try and resolve them, involving all stakeholders.
Collapse
Affiliation(s)
- Philip Timmerman
- European Bioanalysis Forum, Havenlaan 86c b204, Brussels, 1000, Belgium
| | | | - Cecilia Arfvidsson
- Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden
| | - Matthew Barfield
- Roche Innovation Center Welwyn, Roche Pharma Research & Early Development, Welwyn Garden City, Hertfordshire, AL7 1TW, UK
| | - Floris Bove
- J&J Innovative Medicine, Quality Assurance, Beerse, 2340, Belgium
| | - Lea Dalby Brown
- Novo Nordisk A/S, Non-clinical & Clinical Assay Sciences, Novo Nordisk Park, Maaløv, DK-2760, Denmark
| | - Jo Goodman
- AstraZeneca, Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, Cambridge, CB21 6GH, UK
| | - Stuart McDougall
- Quotient Sciences, Bioanalytical Services, Taylor Drive, Alnwick, Northumberland, NE66 2DH, UK
| | - Lee Monk
- Global Quality Assurance, UCB Biopharma UK, Slough, SL1 3WE, UK
| | - Steve White
- GSK, IVIVT-BIB, Gunnells Wood Road, Stevenage, SG1 2NY, UK
| |
Collapse
|
2
|
Timmerman P, Barfield M, Portabella EB, Calogero S, Cowan K, Faber J, Ferrari L, Golob M, Goodman J, Goodwin L, Gnoth MJ, Hughes R, Ivanova T, Jordan G, Laurén A, Maux D, McDougall S, Milushewa P, Nelson R, Pynaert G, Sklodowski K, Sleigh R, Struwe P, Verhaeghe T, Wheller R, White S, Zeiser K. Recommendations and feedback from the European Bioanalysis Forum Workshop: 1 year into ICH M10 - keeping our finger on the pulse. Bioanalysis 2024; 16:259-270. [PMID: 38315622 DOI: 10.4155/bio-2024-0013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2024] Open
Abstract
The ICH M10 guideline on bioanalytical method validation and sample analysis is being adopted since 2023. However, and inevitably, some paragraphs or requirements remain ambiguous and are open for different interpretations. In support of a harmonized interpretation by the industry and health authorities, the European Bioanalysis Forum organized a workshop on 14 November 2023 in Barcelona, Spain, to discuss unclear and/or ambiguous paragraphs which were identified by the European Bioanalysis Forum community and delegates of the workshop prior to the workshop. This manuscript reports back from the workshop with recommendations and aims at continuing an open scientific discussion within the industry and with regulators in support of a science-driven guideline for the bioanalytical community and in line with the ICH mission - that is, achieve greater harmonization worldwide to ensure that safe, effective and high-quality medicines are developed and registered in the most resource-efficient manner.
Collapse
Affiliation(s)
- Philip Timmerman
- European Bioanalysis Forum, Havenlaan 86c b204, Brussels, 1000, Belgium
| | - Matthew Barfield
- Roche Innovation Center Welwyn, Roche Pharma Research & Early Development, Welwyn Garden City, Hertfordshire, AL7 1TW, United Kingdom
| | - Enric Bertran Portabella
- Moderna Innovation & Technology Center, Harwell Science & Innovation Campus. Oxford, OX11 0DF, United Kingdom
| | | | - Kyra Cowan
- Merck KGaA, Research & Development, Drug Metabolism & Pharmacokinetics New Biological Entities, Darmstadt, 64293, Germany
| | - Jörg Faber
- A&M Labor für Analytik und Metabolismusforschung Service GmbH, Bergheim, 50126, Germany
| | - Luca Ferrari
- Roche Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, 4070, Switzerland
| | | | - Jo Goodman
- AstraZeneca, Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, Cambridge, CB21 6GH, United Kingdom
| | - Lee Goodwin
- Labcorp, Bioanalytical Services, Otley Road, Harrogate, HG3 1PY, United Kingdom
| | - Mark Jean Gnoth
- Bayer, DMPK, in vivo PK & bioanalytics, Bayer AG, Wuppertal, 42096, Germany
| | - Richard Hughes
- Resolian Bioanalytics, Newmarket Road, Fordham, CB7 5WW, United Kingdom
| | | | - Gregor Jordan
- Roche Pharma Research & Early Development (pRED), Pharmaceutical Sciences, Bioanalytics & Biomarkers, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, 82377, Germany
| | - Anna Laurén
- MinervaX, Lund, 223 63, Sweden (employed by at the time of writing of this manuscript: Novo Nordisk A/S, Non-clinical & Clinical Assay Sciences, Global Discovery & Development Sciences, Global Drug Discovery, Maaløv, DK-2760, Denmark)
| | - Delphine Maux
- Syneos Health, Clinical Pharmacology & Bioanalysis, Bioanalysis, Biot, 06410, France
| | - Stuart McDougall
- Quotient Sciences, Bioanalytical Services, Taylor Drive, Alnwick, Northumberland, NE66 2DH, United Kingdom
| | | | | | | | - Kamil Sklodowski
- Roche Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, 4070, Switzerland
| | - Rebecca Sleigh
- Resolian Bioanalytics, Newmarket Road, Fordham, CB7 5WW, United Kingdom
| | - Petra Struwe
- Celerion Switzerland AG, Bioanalytical Services, Allmendstrasse, Fehraltorf, 8320, Switzerland
| | - Tom Verhaeghe
- J&J Innovative Medicine, BDDS, Beerse, 2340, Belgium
| | - Robert Wheller
- Resolian Bioanalytics, Newmarket Road, Fordham, CB7 5WW, United Kingdom
| | - Steve White
- GSK, IVIVT-BIB, Gunnells Wood Road, Stevenage, SG1 2NY, United Kingdom
| | - Katja Zeiser
- Nuvisan GmbH, Bioanalysis, Neu-Ulm, 89231, Germany
| |
Collapse
|
3
|
Berry EA, Milner SJ, Bosson M, McDougall S. Comparison of a novel form of zinc with zinc oxide bolus licensed for prevention of facial eczema, and interaction with copper oxide in sheep. Aust Vet J 2023; 101:27-34. [PMID: 36305368 DOI: 10.1111/avj.13211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2022] [Revised: 08/24/2022] [Accepted: 09/09/2022] [Indexed: 02/04/2023]
Abstract
To evaluate a novel elemental zinc bolus compared with a registered positive control zinc oxide bolus and assess serum zinc concentrations following concomitant treatment with a capsule containing copper oxide needles. Forty Romney-cross ewes were randomly allocated in a 2 × 2 factorial design study. On Day 0, 20 ewes received novel boluses containing elemental zinc (Investigational Veterinary Product, IVP) while 20 received a zinc oxide bolus (control; CP). Half the animals in each zinc treatment group (n = 10) were treated with a copper oxide needle capsule [Copasure® - Ewe]. Weekly, from Day -7 to 56, all ewes were assessed for signs of photosensitization, and for 10 ewes from each zinc treatment groups, samples were collected for analysis of serum GGT activity, serum zinc concentrations, faecal zinc concentrations and on Days -7 and 56, liver copper concentrations. Multivariable random-effects models assessed the effects of zinc treatment, copper treatment, treatment interactions and time on all analytes. Regression models examined associations between serum and faecal zinc concentrations and GGT activity. Low spore numbers indicated low Pithomyces chartarum challenge. Serum zinc levels were significantly higher in the IVP than in the CP group [p < 0.0001] and varied by time [p < 0.001] and positively associated with faecal zinc concentration [p < 0.001]. Copper treatment did not affect serum zinc [p = 0.82] or faecal zinc [p = 0.92] concentrations. Liver copper concentrations did not differ between zinc treatment groups on Day -7 [p = 0.6] or Day 56 [p = 0.95]. Only the CP/no copper group had no increase in liver copper concentrations.
Collapse
Affiliation(s)
| | | | - M Bosson
- Cognosco, Morrinsville, New Zealand
| | | |
Collapse
|
4
|
McDougall S, Williamson J, Lacy-Hulbert J. Bacteriological outcomes following random allocation to quarter-level selection based on California Mastitis Test score or cow-level allocation based on somatic cell count for dry cow therapy. J Dairy Sci 2022; 105:2453-2472. [PMID: 35086708 DOI: 10.3168/jds.2021-21020] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2021] [Accepted: 11/22/2021] [Indexed: 01/01/2023]
Abstract
Intramammary infusion of antimicrobials at the end of lactation (dry cow therapy) has been a cornerstone of mastitis management for many years. However, as only a proportion of cows are infected at this time, treating only those cows likely to be infected is an important strategy to reduce antimicrobial usage and minimize risk of emergence of antimicrobial resistance. Such an approach requires the ability to discriminate between cows and quarters likely to be infected and uninfected. This study compared assignment of cows or quarters to antimicrobial treatment at the end of lactation based on cow composite somatic cell count (SCC; i.e., all quarters of cows with a maximum SCC across lactation >200,000 cells/mL received an antimicrobial; n = 891 cows, SCC-group) or assignment to quarter-level treatment based on a quarter level California Mastitis Test (CMT) score ≥ trace (n = 884 cows; CMT-group) performed immediately before drying off. All quarters of all cows also received an infusion of a bismuth-based internal teat sealant. Milk samples were collected for microbiology following the last milking, and again within 4 d of calving. Clinical mastitis records from dry off to 30 d into the subsequent lactation were collected. Multilevel, multivariable models were used to assess the effect of assignment to antimicrobial treatment. At drying off, a total of 575 (8.8%) and 147 (2.3%) of the 6,528 quarters had a minor, and a major intramammary infection (IMI), respectively. At drying off, 2089/3270 (63.9%) and 883/3311 (26.7%) of quarters were treated with dry cow therapy in the CMT and SCC-groups, respectively. Apparent bacteriological cure proportion for any IMI was higher in quarters assigned to the CMT than the SCC-group (349/368 (0.95, 95% CI 0.92-0.97) versus 313/346 (0.90, 95% CI 0.87-0.93)). New IMI proportion was lower among quarters assigned to the CMT than SCC-group [101/3,212 (0.032, 95% CI 0.025-0.038) versus 142/3,232 (0.044, 95% CI 0.036-0.051)]. The prevalence of any IMI postcalving was lower in quarters assigned to the CMT than SCC-group [119/3,243 (0.037, 95% CI: 0.030-0.044) versus 173/3,265 (0.054, 95% CI: 0.045-0.062)]. There was no difference in incidence of clinical mastitis between treatment groups. The total mass of antimicrobials used was 63% higher in the CMT-group than in the SCC-group (3.47 versus 2.12 mg/kg of liveweight). Selection of quarters for antimicrobial treatment at the end of lactation based on CMT resulted in greater proportion undergoing bacteriological cure, reduced risk of any new IMI and reduced post calving prevalence of any IMI compared with selection of cows based on SCC. However, CMT-based selection resulted in higher antimicrobial use compared with SCC-based selection, and further research is required to analyze the cost benefit and impact on risk of antimicrobial resistance of these 2 strategies.
Collapse
Affiliation(s)
- S McDougall
- Cognosco, Anexa, Morrinsville, New Zealand, 3300; School of Veterinary Science, Massey University, Palmerston North, New Zealand, 4442.
| | - J Williamson
- DairyNZ Ltd., Newstead, Hamilton, New Zealand, 3221
| | | |
Collapse
|
5
|
McDougall S, Williamson J, Gohary K, Lacy-Hulbert J. Risk factors for clinical or subclinical mastitis following infusion of internal teat sealant alone at the end of lactation in cows with low somatic cell counts. N Z Vet J 2021; 70:79-87. [PMID: 34487486 DOI: 10.1080/00480169.2021.1977200] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
AIMS To identify risk factors for subclinical and clinical mastitis in cows with low somatic cell counts (SCC) following infusion with internal teat sealant (ITS) at drying off. METHODS Cows with no history of clinical mastitis and a maximum SCC <250,000 cells/mL at any herd test in the lactation before drying off were randomly selected from 36 herds. In the final week of lactation, quarter milk samples were collected aseptically from each selected cow for microbiology, and each quarter was then infused with ITS. Clinical mastitis records from 22 herds and herd test data from all herds were collated to determine potential herd- or cow-level explanatory variables for clinical mastitis over the dry period or in the first 60 days of the subsequent lactation, and subclinical mastitis (SCC >200,000 cells/mL; SCM) at the first herd test after calving. Multivariable, multilevel, logistic regression analyses were used to model the data. RESULTS At drying off, 44/1,514 (2.8%) cows were infected with a major pathogen. Two of 1,001 (0.2%) cows were diagnosed with clinical mastitis over the dry period. There were 128/1,514 (8.5%) cows with SCM at the first herd test after calving. The odds of SCM were greater for cows with a major pathogen present at drying off than those without (OR = 4.7 (95% CI = 2.29-9.65); p < 0.001), and for third or greater lactation than second lactation cows (OR = 3.16 (95% CI = 1.70-5.88); p < 0.001). For every 1L increase in milk yield at the last herd test before drying off the OR for SCM was 1.07 (95% CI = 1.01-1.13); (p = 0.02), and for each 1 unit increase in ln maximum SCC in the lactation before drying off the OR for SCM was 1.54 (95% CI = 1.13-2.10); (p = 0.01). There were 30/976 (3.1%) cows diagnosed with clinical mastitis in the first 60 days after calving. The odds of clinical mastitis were greater for cows producing >15 L/day at the last herd test of the preceding lactation than cows producing <10 L/day (OR = 4.79 (95% CI = 1.48-15.46); p = 0.009); for each 1 unit increase in ln maximum SCC in the previous lactation the OR for clinical mastitis was 1.96 (95% CI = 1.09-3.54); (p = 0.03), and the odds increased with increasing herd-level cow-case lactational incidence of clinical mastitis in the preceding lactation (p = 0.003). CONCLUSIONS AND CLINICAL RELEVANCE Selection of cows with low SCC for ITS infusion should consider cow milk yield and maximum cow SCC in the preceding lactation.
Collapse
Affiliation(s)
| | | | - K Gohary
- Cognosco, Anexa, Morrinsville, New Zealand
| | | |
Collapse
|
6
|
Abstract
AIMS To develop an intrauterine infection model for Trueperella pyogenes in postpartum dairy cows and to assess the effect of this infection on the degree of intrauterine inflammation and concentrations of progesterone in serum. METHODS The oestrous cycles of 36 healthy, non-pregnant, postpartum dairy cows were synchronised. They were then treated by intrauterine infusion of 0.5 g cephapirin before being blocked by age and randomly assigned to treatment with intrauterine infusion of saline (n = 18), 107 (n = 9) or 109 (n = 9) cfu of T. pyogenes, approximately 4 days after the expected time of ovulation (Day 0). Prior to intrauterine infusion on Day 0 and again on Days 3, 7, 10, and 15, cytobrush samples were collected from the uterus of each cow for microbiology and assessment of the percentage of polymorphonuclear neutrophils (PMN%). Blood samples were collected on the same days for measurement of concentrations of progesterone in serum, and uterine lumen diameter was assessed daily using transrectal ultrasonography. RESULTS Trueperella pyogenes was isolated from 5/18 (28%), 7/9 (78%) and 8/9 (89%) cows infused with saline, 107 or 109 cfu of T. pyogenes, respectively (p < 0.001). Mean PMN% in the control cows did not change over time (p > 0.05), whereas it was higher on Days 7 and 10 than Day 0 in the 107 cfu group, and higher on Days 3 and 10 than Day 0 in the 109 cfu group (p < 0.05). The percentage of observations with uterine lumen diameters >2 mm was higher in cows infused with 107 (29.3 (95% CI = 14.5-44.2)%) or 109 cfu (19.2 (95% CI = 7.0-31.5)%) than in control cows (3.1 (95% CI = 0.1-6.0)%) (p < 0.001). Mean concentrations of progesterone in serum were higher in cows infused with 107 cfu (2.01 (SE 0.19) ng/mL) than cows infused with 109 cfu (1.01 (SE 0.27) ng/mL), with the control group intermediate (1.41 (SE 0.19) ng/mL) (p = 0.03). CONCLUSIONS Infusion of 107 or 109 cfu of T. pyogenes resulted in the establishment of intrauterine infection in 83% of cows. Infection resulted in increased uterine lumen diameter, and an inflammatory response, i.e. elevated PMN%. CLINICAL RELEVANCE This intrauterine infection model may be useful for future research on, for example, the pathogenesis of intrauterine infection in postpartum dairy cows.
Collapse
Affiliation(s)
- S McDougall
- Cognosco, Anexa, Morrinsville, New Zealand.,School of Veterinary Science, Massey University, Palmerston North, New Zealand
| | - E M Graham
- Cognosco, Anexa, Morrinsville, New Zealand
| | - D Aberdein
- School of Veterinary Science, Massey University, Palmerston North, New Zealand
| | - C B Reed
- DairyNZ Ltd., Newstead, New Zealand
| | | |
Collapse
|
7
|
McDougall S, Castle R. Cow-level risk factors for clinical mastitis in the dry period in cows treated with an internal teat sealant alone at the end of lactation. N Z Vet J 2021; 69:327-336. [PMID: 34061718 DOI: 10.1080/00480169.2021.1938269] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
AIMS To assess potential cow-level risk factors for clinical mastitis during the dry period in cows infused with internal teat sealant (ITS) alone at drying off, and associations with elevated somatic cell counts (SCC) at the first herd test, or clinical mastitis in the subsequent lactation. METHODS Ten herds reporting an incidence of clinical mastitis during the dry period of >3% amongst cows infused with ITS alone at the end of the 2018/2019 lactation were enrolled. Cow data collected included age, breed, milk yield and SCC at the last herd test before drying off, drying off date, clinical mastitis records during the dry period and in the subsequent lactation, and SCC at the first herd test following calving. RESULTS Overall, 2,401 cows were infused with ITS alone and 196/2,401 (8.2%) cows were diagnosed with clinical mastitis during the dry period. In the final multivariable model for risk of clinical mastitis there was an interaction between age and milk yield at the last herd test (p < 0.001), with cows aged >4 years and producing ≥10 L/cow/day having a higher risk of clinical mastitis than younger cows or those producing <10 L/cow/day. The risk of clinical mastitis was higher for cows dried off in the last week of lactation than for cows dried off >1 week before the end of lactation for the herd (p = 0.033). The percentage of cows with elevated SCC (>150,000 cells/mL) at the first herd test in the following lactation was higher amongst those diagnosed with clinical mastitis over the dry period compared with those that were not (p = 0.048). The hazard of clinical mastitis in the first 60 days after calving was also higher in cows diagnosed with clinical mastitis in the dry period than those that were not (p < 0.001). CONCLUSIONS AND CLINICAL RELEVANCE The risk of clinical mastitis in the dry period following infusion of ITS alone at the end of lactation was associated with cow age, milk yield before drying off and timing of drying off. Cows diagnosed with clinical mastitis over the dry period had a higher risk of clinical mastitis and of elevated SCC in the subsequent lactation. This was an observational study so no causal inferences can be made, however herdowners and veterinarians should follow current recommendations regarding management of milk yield before drying off, and selection of cows for treatment with ITS alone.
Collapse
Affiliation(s)
| | - R Castle
- Bayer New Zealand Ltd, Auckland, New Zealand
| |
Collapse
|
8
|
McDougall S. Evaluation of fully oxidised β-carotene as a feed ingredient to reduce bacterial infection and somatic cell counts in pasture-fed cows with subclinical mastitis. N Z Vet J 2021; 69:285-293. [PMID: 33944703 DOI: 10.1080/00480169.2021.1924091] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
AIMS To assess the effect of oral supplementation with fully oxidised β-carotene (OxBC) on bacteriological cure, the incidence of clinical mastitis, and somatic cell counts (SCC) in pasture-fed cows with subclinical intramammary infection. METHODS Cows from four dairy herds were enrolled in early lactation if they had quarter-level SCC >200,000 cells/mL and they had a recognised bacterial intramammary pathogen in one or more quarters. They were randomly assigned to be individually fed from Day 0, for a mean of 40 days, with 0.5 kg of a cereal-based supplementary feed that either contained 300 mg of OxBC (treatment; n = 129 quarters) or did not (control; n = 135 quarters). Quarter-milk samples were collected on Days 21 and 42 for microbiology and SCC assessment. Bacteriological cure was defined as having occurred when the bacteria present on Day 0 were not isolated from samples collected on Days 21 or 42. A new intramammary infection was defined as a bacterial species isolated either on Day 21 or 42 differing from that isolated on Day 0. Clinical mastitis was diagnosed and recorded by herdowners up to Day 42. RESULTS The bacteriological cure rate was greater for quarters from cows in the treatment group (13.9 (95% CI = 4.1-23.7)%) than for cows in the control group (6.9 (95% CI = 4.8-9.1)%; p = 0.02). The percentage of quarters that developed a new intramammary infection at Day 21 or 42 was greater for cows in the treatment group (17.9 (95% CI = 6.7-29.1)%) than for cows in the control group (13.0 (95% CI = 4.3-21.8)%; p < 0.01). The prevalence of quarters that were infected on Day 42 was less in cows in the treatment group (79.9 (95% CI = 62.3-97.6)%) than the control group (88.2 (95% CI = 78.4-97.9)%; p = 0.009). The incidence of quarters diagnosed with clinical mastitis by Day 42 was lower in cows from the treatment group (1/129 (0.78 (95% CI = 0.02-4.24)%)) than in cows from the control group (6/135 (4.44 (95% CI = 1.65-9.42)%; p = 0.03)). Mean quarter-level SCC was not statistically different between treatment groups (p = 0.34). CONCLUSIONS AND CLINICAL RELEVANCE Feeding 300 mg/cow/day of OxBC resulted in a higher bacteriological cure rate, a lower prevalence of intramammary infection, and a lower incidence of clinical mastitis compared to untreated controls. However new intramammary infections increased in treated cows, and the magnitude of the increased bacteriological cure was low, resulting in 80% of cows remaining infected at Day 42. Therefore treatment with OxBC should be considered as an adjunct to other mastitis control measures.
Collapse
|
9
|
McDougall S, Williamson J, Gohary K, Lacy-Hulbert J. Detecting intramammary infection at the end of lactation in dairy cows. J Dairy Sci 2021; 104:10232-10249. [PMID: 34053762 DOI: 10.3168/jds.2020-20036] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2020] [Accepted: 04/18/2021] [Indexed: 11/19/2022]
Abstract
To reduce antimicrobial use, infusion of antimicrobials into only infected cows at the end of lactation (selective dry cow therapy) is preferable to infusion of every cow with antimicrobials. Use of selective dry cow antimicrobial therapy requires differentiation of probably infected from uninfected cows to enable treatment allocation. Milk somatic cell count (SCC) has been used to distinguish between cows with and without intramammary infection (IMI). However, SCC may be influenced by milk yield, stage of lactation, breed, and herd-level variables such as prevalence of infection. Cut points for SCC, to distinguish between cows with and without an IMI, may need to differ between cow age groups and breeds, or among herds. This study evaluated associations between SCC and major pathogen IMI in one or more quarters of 2,606 cows from 36 herds in 4 regions of New Zealand. In the last week of lactation, cows selected at random had milk samples collected from each quarter, and the teat-end condition and hygiene of the udder were scored. Herd- and cow-level data including age, breed, milk volume, and SCC at each production were recorded, and bulk tank milk SCC and volume of milk shipped were collated. At cow level, the association between average, maximum, and last cow-composite SCC, and presence of a major pathogen IMI in one or more quarters of cows, was examined using receiver operator curves. Predictive logistic regression models were then developed that included potential effect modifiers such as age, milk yield, and bulk tank milk SCC. The population average prevalence of major pathogen IMI was 7.2% of cows (95% confidence interval = 5.9-8.6), and this varied significantly between herds. The average, maximum, and last cow-composite SCC of lactation were all predictive of presence of a major pathogen IMI and did not differ in their ability to discriminate infected from uninfected cows. However, the optimal cut points for the last SCC, the maximum SCC, and average SCC were 108, 152, and 105 × 1,000 cells/mL, respectively. Inclusion of age, bulk tank SCC, and history of clinical mastitis improved overall model fit. However, inclusion of these variables did not improve the discriminatory power of maximum cow-composite SCC used alone. We conclude that cow-composite SCC on its own resulted in sensitivities and specificities of between 0.76 and 0.86, and 0.71 to 0.80, respectively, for determination of presence of major pattern IMI, and the predictive value was not improved by addition of other predictor variables.
Collapse
Affiliation(s)
- S McDougall
- Cognosco, Anexa FVC, PO Box 21, Morrinsville, 3300, New Zealand.
| | - J Williamson
- DairyNZ Ltd., Private Bag 3221, Hamilton, 3240, New Zealand
| | - K Gohary
- Cognosco, Anexa FVC, PO Box 21, Morrinsville, 3300, New Zealand
| | - J Lacy-Hulbert
- DairyNZ Ltd., Private Bag 3221, Hamilton, 3240, New Zealand
| |
Collapse
|
10
|
McDougall S, Penry J, Dymock D. Antimicrobial susceptibilities in dairy herds that differ in dry cow therapy usage. J Dairy Sci 2021; 104:9142-9163. [PMID: 34001359 DOI: 10.3168/jds.2020-19925] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2020] [Accepted: 03/28/2021] [Indexed: 11/19/2022]
Abstract
Intramammary infusion of antimicrobials at the end of lactation (dry cow therapy; DCT) is a central part of mastitis control programs and is one of the major indications for antimicrobial use in dairy cows. However, with increasing focus on prudent use of antimicrobials and concerns about emergence of antimicrobial resistance, the practice of treating every cow at the end of lactation with DCT is in question. This cross-sectional, observational study determined the minimum inhibitory concentrations (MIC) of 10 antimicrobials for coagulase-negative staphylococci (CNS), Staphylococcus aureus, Streptococcus dysgalactiae, and Streptococcus uberis isolates from milk samples from dairy cows with somatic cell counts >200,000 cells/mL in herds that had been organic for >3 yr (n = 7), or had used either ampicillin-cloxacillin DCT (n = 11) or cephalonium DCT (n = 8) in the preceding 3 yr. The organic herds were certified under the United States Department of Agriculture National Organic Program, meaning that there was no blanket DCT, and minimal use of antimicrobials in general, with a loss of organic status of the animal if treated with antimicrobials. Breakpoints (where available) were used to categorize isolates as resistant, intermediate, or susceptible to antimicrobials. The MIC distributions of isolates from different herd types were compared using binomial or multinomial logistic regression. Of 240 CNS isolates, 12.9, 0.8, 7.1, 32.6, and 1.2%, were intermediate or resistant to ampicillin, cephalothin, erythromycin, penicillin, and tetracycline, respectively. Of 320 Staph. aureus isolates, 29.0, 2.5, 1.2, and 34.9% were intermediately resistant or resistant to ampicillin, penicillin, erythromycin, and oxacillin, respectively. Of 184 Strep. uberis isolates, 1.1, 25.0, 1.6, and 1.6% were intermediately resistant or resistant to erythromycin, penicillin, pirlimycin, and tetracycline, respectively. Generally, the MIC of CNS and streptococcal isolates from organic herds were lower than isolates from herds using DCT. However, the differences in MIC distributions occurred at MIC below clinical breakpoints, so that the bacteriological cure rates may not differ between isolates of differing MIC. Bimodal distributions of MIC for ampicillin and penicillin were found in Staph. aureus isolates from organic herds, suggesting that isolates with a higher MIC are a natural part of the bacterial population of the bovine mammary gland, or that isolates with higher MIC have persisted within these organic herds from a time when antimicrobials had been used. Given these observations, further work is required to determine if exposure to DCT is causally associated with the risk of elevated MIC, and whether reduction or removal of DCT from herds would reduce the risk of elevated MIC of mastitis pathogens.
Collapse
Affiliation(s)
- S McDougall
- Cognosco, Anexa, PO Box 21, Morrinsville 3300, New Zealand.
| | - J Penry
- Cognosco, Anexa, PO Box 21, Morrinsville 3300, New Zealand
| | - D Dymock
- MSD, Upper Hutt 5140, New Zealand
| |
Collapse
|
11
|
McDougall S, Castle R, Blythe E, Macpherson Y, Karkaba A. Increasing conception rate by addition of a second prostaglandin injection in an Ovsynch and progesterone treatment programme for dairy cows not detected in oestrus before the start of the seasonal mating period. N Z Vet J 2021; 69:211-223. [PMID: 33960911 DOI: 10.1080/00480169.2021.1906343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
AIMS To assess the effect on conception rate to first service, 3- and 6-week in-calf rates, final pregnancy rate and the hazard of pregnancy, of addition of a second prostaglandin (PG) injection 24 hours after the first, in a synchrony programme combining Ovsynch and progesterone in pasture-based dairy cows that had not been detected in oestrus before the start of the seasonal mating period. METHODS This prospective, negative-controlled study was conducted using anoestrous cows (n = 1,411) from nine spring-calving dairy herds in the Waikato region of New Zealand. Ovaries of cows not detected in oestrus were examined by transrectal ultrasonography and the presence of a corpus luteum determined. All cows were then treated with an intravaginal progesterone-releasing device and injected I/M with gonadorelin (Day -9). Cows were injected I/M with cloprostenol at device removal (Day -2) and on Day -1 were injected with either water (single PG; n = 720), or cloprostenol (double PG; n = 692). On Day 0 cows were injected again with gonadorelin, unless previously detected in oestrus, and were inseminated on Day 1. Based on dated pregnancy diagnosis by transrectal ultrasonography, cows were categorised as conceiving to first insemination, becoming pregnant in the first 3 or 6 weeks, or becoming pregnant by the end of the mating period. RESULTS Cows in the double PG group had increased conception rate to first service (45.3 (95% CI = 45.1-45.4)% vs. 41.1 (95% CI = 41.0-41.3)%; p < 0.001), 3-week in-calf rate (53.4 (95% CI = 53.6-54.0)% vs. 49.2 (95% CI = 49.0-49.4)%; p < 0.001), and 6-week in-calf rate (67.2 (95% CI = 65.7-68.8)% vs. 63.5 (95% CI = 62.0-65.0)%; p = 0.014) compared to cows in the single PG group. Final pregnancy rate and hazard of pregnancy did not differ between treatment groups (p >0.2). CONCLUSIONS Addition of a second PG injection 24 hours after the first, increased conception rate to first service and the proportion of cows pregnant by 3 and 6 weeks after commencement of the mating period. CLINICAL RELEVANCE Improved outcomes can be achieved when treating those cows not detected in oestrus by the start of the seasonal mating period by addition of a second PG injection to the currently recommended treatment protocol for these animals.
Collapse
Affiliation(s)
| | - R Castle
- Elanco Animal Health LTD, Manukau City, Auckland, New Zealand
| | - E Blythe
- Cognosco, Anexa, Morrinsville, New Zealand
| | | | - A Karkaba
- Cognosco, Anexa, Morrinsville, New Zealand
| |
Collapse
|
12
|
McDougall S, Aberdein D, Bates A, Burke CR. Prevalence of endometritis diagnosed by vaginal discharge scoring or uterine cytology in dairy cows and herds. J Dairy Sci 2020; 103:6511-6521. [PMID: 32359992 DOI: 10.3168/jds.2019-18048] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2019] [Accepted: 02/21/2020] [Indexed: 11/19/2022]
Abstract
Endometritis, diagnosed either by assessing the proportion of nucleated cells that are neutrophils (PMN%) following cytology of the endometrium or by assessing the degree of purulent material within the vagina (purulent vaginal discharge or PVD score), is prevalent among dairy cows. However, limited data exist as to the degree of variation among herds in the prevalence of endometritis diagnosed by these 2 methods. Thus, we undertook a study involving uterine cytological and vaginal sampling at a median of 41 d in milk of 1,807 cows from 100 seasonally breeding dairy herds in New Zealand. The optimal cut-point for PMN% was determined by receiver operator characteristic (ROC) curve analysis using conception to first artificial insemination (AI) as the outcome variable. The prevalence of disease was then calculated at the cow and herd levels, and an estimate of the effect of clustering of cow within a herd was calculated. Reproductive outcomes were collated and associations between endometritis and reproductive outcomes assessed using multivariable models. The optimal PMN% cut-point was ≥2%. The correlation of results for cows within a herd (the intraclass correlation) was 0.03, which was significant; hence, subsequent modeling accounted for this clustering. The cow-level prevalence of PMN% ≥2% was 27.0% [95% confidence interval (CI): 25.0 to 29.1%], whereas the mean within-herd prevalence of PMN% ≥2% was 27.1% (95% CI: 24.7 to 29.6%; range: 5.0 to 63.6%), and the prevalence among herds varied significantly. An elevated PMN% (≥2%) was significantly associated with a reduction in the proportion of cows conceiving to first AI (45.8 vs. 54.5%), a reduced proportion of cows submitted for AI in the first 3 wk of the seasonal breeding program (83.7 vs. 89.3%), and a lower proportion pregnant in the first 3 (44.4 vs. 55.4%) and 6 wk (67.5 vs. 76.4%) of the breeding program relative to cows with a low PMN% (i.e., <2%). A total of 24.6% of cows had a PVD score ≥2. The herd mean prevalence of PVD score ≥2 was 25.1% (95% CI: 22.5 to 27.7%; range: 5.0 to 65.0%) and varied significantly among herds. The level of agreement (kappa) between the PVD score and PMN% was low (16.8%) and nonsignificant. The effects of PVD score and PMN% on reproductive outcomes were independent. The within-herd median prevalence of endometritis based on combining both diagnostic tests and using a Bayesian latent class model was 22.9% (Bayesian 95% CI: 10.4 to 40.1%). We conclude that more than one-fifth of dairy cows have endometritis diagnosed either by PMN% or PVD in seasonal breeding herds when assessed at an average of 41 DIM, which was, on average, 30 d before the start of the seasonal breeding program. There is large and unexplained variation in prevalence of endometritis among herds. The 2 diagnostic methods were both associated with reproductive outcomes but have low levels of agreement between them and their effects appear to be independent.
Collapse
Affiliation(s)
- S McDougall
- Cognosco, Anexa, Morrinsville 3300, New Zealand.
| | - D Aberdein
- School of Veterinary Science, Massey University, Palmerston North 4442, New Zealand
| | - A Bates
- Vetlife, Temuka 7920, New Zealand
| | - C R Burke
- DairyNZ Ltd., Hamilton 3240, New Zealand
| |
Collapse
|
13
|
Castle R, McDougall S. Introducing herd level antimicrobial susceptibility data into the veterinarian-dairy farmer relationship. Aust Vet J 2019; 97:289. [PMID: 31359428 DOI: 10.1111/avj.12813] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2019] [Accepted: 03/20/2019] [Indexed: 11/28/2022]
Affiliation(s)
- R Castle
- Bayer Animal Health, PO Box 76369, Manukau, 2241, New Zealand
| | | |
Collapse
|
14
|
McDougall S, Clausen L, Hintukainen J, Hunnam J. Randomized, controlled, superiority study of extended duration of therapy with an intramammary antibiotic for treatment of clinical mastitis. J Dairy Sci 2019; 102:4376-4386. [PMID: 30879816 DOI: 10.3168/jds.2018-15141] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2018] [Accepted: 01/28/2019] [Indexed: 11/19/2022]
Abstract
The objectives of this study were to evaluate the efficacy of therapy of clinical mastitis following intramammary infusion of 2 durations of intramammary antibiotic therapy and to analyze clinical and microbiology data at enrollment or within 4 d of commencement of treatment as potential predictors of subsequent clinical and bacteriological cure. A total of 304 glands were randomly assigned to intramammary treatment with a combination of amoxicillin, clavulanic acid, and prednisolone either 3 times at 12-h intervals (3×12, n = 156) or 5 times at 12-h intervals (5×12 hourly, n = 148). At enrollment (d 0), assessments were made of the cow's demeanor, rectal temperature, teat-end hyperkeratosis, presence of heat or swelling of the gland, presence of clots in the milk, and California Mastitis Test (CMT) score. Cows were revisited on d 4, 14, and 21 and assessed for rectal temperature, the presence of clots in milk, heat or swelling of the gland, and CMT score. Milk samples were collected from enrolled glands for bacteriology (d 0, 4, 14, and 21) and for somatic cell count (d 14 and 21). Data were analyzed using generalized linear models. Treatment group was the key independent variable, but herd was included in the models. Other potentially confounding variables were included where associated at the bivariate level. A second series of analyses were undertaken to predict likelihood of clinical and bacteriological cure using the clinical signs cow age and days in milk, as well as bacteriological results at d 0 and 4. Although we found a higher clinical failure rate in the 3×12 than 5×12 hourly treatment group (28.2 ± 5.0 vs. 13.4 ± 3.6%, respectively), we noted no difference in bacteriological cure percentage (73.3 ± 7.8 vs. 72.0 ± 7.4%, respectively). The presence of heat or swelling at d 4, days in milk at initiation of treatment, age of the cow, and change in CMT score between d 0 and 4 were predictive of clinical and bacteriological cure. We concluded that increasing the duration of treatment resulted in significantly fewer clinical failures, but had no effect on cure proportion, somatic cell count, or new infection rate. Knowledge of cow age and days in milk and clinical signs were predictive of clinical and bacteriological cure proportion and may provide guidance for producers, under veterinary direction, as to when to extend or recommence therapy.
Collapse
Affiliation(s)
- S McDougall
- Cognosco, AnexaFVC, Morrinsville 3300, New Zealand.
| | - L Clausen
- Cognosco, AnexaFVC, Morrinsville 3300, New Zealand
| | - J Hintukainen
- Faculty of Veterinary Medicine, University of Helsinki, 00014 Helsinki, Finland
| | - J Hunnam
- Cognosco, AnexaFVC, Morrinsville 3300, New Zealand; Department of Economic Development, Jobs, Transport and Resources, Attwood, Victoria 3049, Australia
| |
Collapse
|
15
|
Roberts KI, McDougall S. Risk factors for subclinical hypocalcaemia, and associations between subclinical hypocalcaemia and reproductive performance, in pasture-based dairy herds in New Zealand. N Z Vet J 2018; 67:12-19. [DOI: 10.1080/00480169.2018.1527732] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- KI Roberts
- Cognosco, AnexaFVC, Moorhouse St, PO Box 21, Morrinsville, New Zealand
| | - S McDougall
- Cognosco, AnexaFVC, Moorhouse St, PO Box 21, Morrinsville, New Zealand
| |
Collapse
|
16
|
Roberts KI, Bennison J, McDougall S. Effect of treatment with oral Ca boluses following calving on concentrations of Ca in serum in pasture-based dairy cows. N Z Vet J 2018; 67:20-26. [PMID: 30208799 DOI: 10.1080/00480169.2018.1520654] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
AIMS To assess the effect of the administration of two oral Ca boluses on concentrations of total Ca, β-hydoxybutyrate (BHB) and non-esterified fatty acids (NEFA) in serum, and urine pH, in recently calved pasture-fed dairy cows. METHODS Friesian or Friesian cross Jersey cows from one dairy farm were blocked by age and randomly assigned to no treatment (control; n=14), or treatment (n=13) with two oral Ca boluses administered approximately 12 hours apart, with the first bolus being given within 14 hours of calving. Each bolus weighed 198 g and contained 43 g of Ca; 31 g of Ca from calcium chloride and 12 g of Ca from calcium sulfate. Cows were enrolled over three calendar days, and all cows were managed in one group during the 24-hour study period. Blood samples were collected at 0, 1, 2, 4, 8, 12, 13, 14, 16, 20 and 24 hours after the initial treatment. Serum from each time point was analysed for concentrations of total Ca, and from 0, 12, and 24 hours for NEFA and BHB. Urine was collected at 0, 12 and 24 hours for pH measurement and pH was categorised as <7 or ≥7. The effect of treatment on percentage change in concentrations of Ca in serum relative to 0 hours, and concentrations of NEFA, BHB and urine pH, was examined using multivariable repeated measures mixed models with cow as a random effect. RESULTS In the final multivariable model for percentage change in concentrations of Ca, there was an interaction between time and treatment (p=0.004), with the percentage increase being higher in treatment than control cows at 1, 2, 4, 8 and 13 hours. At 12 hours, 5/13 (41%) treated cows had a urine pH <7compared to 0/12 (0%) control cows (p<0.001), and at 24 hours 13/13 (100%) treated cows had urine pH <7 compared to 0/12 (0%) control cows (p<0.001). Over the 24-hour period, mean concentrations of NEFA or BHB in serum were similar in treated and control cows (p>0.3). CONCLUSIONS AND CLINICAL RELEVANCE Oral treatment with two Ca boluses increased concentrations of total Ca in serum and decreased urine pH in pasture-fed cows. This bolus has the potential to reduce the prevalence and duration of subclinical hypocalcaemia in recently calved cows.
Collapse
Affiliation(s)
- K I Roberts
- a Cognosco, AnexaFVC , PO Box 21, Morrinsville , 3330 , New Zealand
| | - J Bennison
- b Agrimin , Arlanda Way, Humberside Airport, Kirmington, North Lincolnshire , DN39 6YH , UK
| | - S McDougall
- a Cognosco, AnexaFVC , PO Box 21, Morrinsville , 3330 , New Zealand
| |
Collapse
|
17
|
Heiser A, LeBlanc S, McDougall S. Pegbovigrastim treatment affects gene expression in neutrophils of pasture-fed, periparturient cows. J Dairy Sci 2018; 101:8194-8207. [DOI: 10.3168/jds.2017-14129] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2017] [Accepted: 05/17/2018] [Indexed: 01/28/2023]
|
18
|
Affiliation(s)
- K Gohary
- Cognosco, Anexa FVC, PO Box 21, Morrinsville 3340, New Zealand
| | - S McDougall
- Cognosco, Anexa FVC, PO Box 21, Morrinsville 3340, New Zealand
| |
Collapse
|
19
|
Somaa FA, Wang TY, Niclis JC, Bruggeman KF, Kauhausen JA, Guo H, McDougall S, Williams RJ, Nisbet DR, Thompson LH, Parish CL. Peptide-Based Scaffolds Support Human Cortical Progenitor Graft Integration to Reduce Atrophy and Promote Functional Repair in a Model of Stroke. Cell Rep 2018; 20:1964-1977. [PMID: 28834757 DOI: 10.1016/j.celrep.2017.07.069] [Citation(s) in RCA: 66] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2017] [Revised: 06/07/2017] [Accepted: 07/24/2017] [Indexed: 12/22/2022] Open
Abstract
Stem cell transplants offer significant hope for brain repair following ischemic damage. Pre-clinical work suggests that therapeutic mechanisms may be multi-faceted, incorporating bone-fide circuit reconstruction by transplanted neurons, but also protection/regeneration of host circuitry. Here, we engineered hydrogel scaffolds to form "bio-bridges" within the necrotic lesion cavity, providing physical and trophic support to transplanted human embryonic stem cell-derived cortical progenitors, as well as residual host neurons. Scaffolds were fabricated by the self-assembly of peptides for a laminin-derived epitope (IKVAV), thereby mimicking the brain's major extracellular protein. Following focal ischemia in rats, scaffold-supported cell transplants induced progressive motor improvements over 9 months, compared to cell- or scaffold-only implants. These grafts were larger, exhibited greater neuronal differentiation, and showed enhanced electrophysiological properties reflective of mature, integrated neurons. Varying graft timing post-injury enabled us to attribute repair to both neuroprotection and circuit replacement. These findings highlight strategies to improve the efficiency of stem cell grafts for brain repair.
Collapse
Affiliation(s)
- Fahad A Somaa
- The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3052, Australia
| | - Ting-Yi Wang
- The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3052, Australia
| | - Jonathan C Niclis
- The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3052, Australia
| | - Kiara F Bruggeman
- Laboratory of Advanced Materials, Research School of Engineering, The Australian National University, Canberra, ACT 2601, Australia
| | - Jessica A Kauhausen
- The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3052, Australia
| | - Haoyao Guo
- The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3052, Australia
| | - Stuart McDougall
- The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3052, Australia
| | | | - David R Nisbet
- Laboratory of Advanced Materials, Research School of Engineering, The Australian National University, Canberra, ACT 2601, Australia
| | - Lachlan H Thompson
- The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3052, Australia.
| | - Clare L Parish
- The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3052, Australia.
| |
Collapse
|
20
|
McDougall S, Leane S, Butler S, Roche J, Burke C. Effect of altering the type of dietary carbohydrate early postpartum on reproductive performance and milk production in pasture-grazed dairy cows. J Dairy Sci 2018; 101:3433-3446. [DOI: 10.3168/jds.2016-12421] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2016] [Accepted: 12/18/2017] [Indexed: 11/19/2022]
|
21
|
Denholm KS, McDougall S, Chambers G, Clough W. Factors associated with colostrum quality in individual cows from dairy herds in the Waikato region of New Zealand. N Z Vet J 2018; 66:115-120. [PMID: 29268053 DOI: 10.1080/00480169.2017.1418684] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
AIMS To examine associations between various cow-level factors and quality of first-milking colostrum (measured as Brix), and to evaluate herd-level associations between vaccination against calf diarrhoea and colostrum quality, in cows from dairy herds in the Waikato region of New Zealand. METHODS A single colostrum sample was collected, by complete udder evacuation, from each of 20 cows from 29 dairy herds in the Waikato region of New Zealand during the 2016 spring calving period. Vaccination pre-partum with a calf diarrhoea vaccine was used in 15 herds. Each colostrum sample was tested using a digital Brix refractometer. The body condition score of each cow was recorded at the time of sample collection and farmers provided records of clinical mastitis and facial eczema from the previous 12 months, as well as the age and breed of cows. Associations between cow-level variables in non-vaccinated herds and Brix were examined using a multivariable linear mixed model and estimated marginal means obtained for different categories. RESULTS Mean Brix of 281 samples from cows in non-vaccinated herds was 18.7 (SD 0.26)%; 63/281 (22.4%) samples had Brix ≥22% and 152/281 (54.1%) had Brix ≥18%. Mean Brix of colostrum samples from cows aged ≥6 years (20.2 (95% CI=19.1-21.2)%) was higher than for samples from 2-year-old cows (18.6 (95% CI=17.3-19.9)%) (p=0.005). Colostrum that was collected at the first milking on the day of calving had higher Brix (20.0 (95% CI=19.1-20.9)%) than colostrum collected from cows that calved the previous day (17.5 (95% CI=16.5-18.4)%) (p<0.001). Mean Brix of colostrum samples from cows which produced ≥8 L (18.2 (95% CI=17.1-19.2)%) tended to be lower than from cows which produced <8 L first-milking colostrum (19.1 (95% CI=18.3-20.0)%) (p=0.08). Among vaccinating herds, 9/15 (60%) had ≥60% colostrum samples with Brix ≥18% compared with 4/14 (29%) of non-vaccinating herds (p=0.04). CONCLUSIONS AND CLINICAL RELEVANCE Colostrum quality, as measured by Brix, was associated with the total volume of first-milking colostrum, interval from calving to colostrum collection and cow age. Vaccination against calf diarrhoea was associated with a higher proportion of colostrum samples with adequate Brix. Careful selection of colostrum donor cows should ensure newborn calves are fed adequate quality colostrum which should be beneficial in preventing failure of passive transfer of IgG. Testing of colostrum from individual cows with a Brix refractometer is advocated for the selection of colostrum for feeding newborn calves.
Collapse
Affiliation(s)
- K S Denholm
- a Anexa FVC , 1126 Gordonton Road, Taupiri 3791 , New Zealand
| | - S McDougall
- b Cognosco , 25 Moorhouse Street, Morrinsville 3340 , New Zealand
| | - G Chambers
- c Zoetis NZ Ltd ., Level 5, 8 Mahuhu Crescent, Auckland 1010 , New Zealand
| | - W Clough
- c Zoetis NZ Ltd ., Level 5, 8 Mahuhu Crescent, Auckland 1010 , New Zealand
| |
Collapse
|
22
|
McDougall S, Niethammer J, Graham EM. Antimicrobial usage and risk of retreatment for mild to moderate clinical mastitis cases on dairy farms following on-farm bacterial culture and selective therapy. N Z Vet J 2018; 66:98-107. [PMID: 29241025 DOI: 10.1080/00480169.2017.1416692] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
AIMS To assess antimicrobial usage for treatment of mild to moderate clinical mastitis, and risk of retreatment, following implementation of an on-farm bacterial culture system and selective therapy based on culture results, and to assess compliance with treatment decision tree protocols and the level of agreement between results from on-farm culture and laboratory-based microbiology methods. MATERIALS AND METHODS Herdowners from seven dairy herds were asked to collect milk samples from cases of mild to moderate clinical mastitis between July 2015 and May 2016. All samples were cultured on-farm using a commercially available selective media and were also submitted for laboratory-based culture. Within sequential pairs of cows with mastitis, half were assigned to be treated without regard to culture results (Blanket group), and half were treated based on the on-farm culture results (Selective group) according to decision tree diagrams provided to the farmers. Culture results, treatments, and retreatments for clinical mastitis were recorded. The sum of the daily doses of antimicrobials used per cow, the number of retreatments and interval to first retreatment were compared between treatment groups. RESULTS The geometric mean sum of daily doses for quarters assigned to the Selective (1.72 (95% CI=1.55-1.90)) group was lower than for the Blanket (2.38 (95% CI=2.17-2.60)) group (p=0.005). The percentage of cows retreated for clinical mastitis did not differ between the Selective (21.7 (95% CI=10.5-25.9)%) and Blanket (26.1 (95% CI=20.9-31.3)%) groups (p=0.13), and there was no difference between groups in the hazard that cows would be retreated within 60 days of enrolment (hazard ratio=0.82 (95% CI=0.39-1.69); p=0.59). Compliance with the treatment protocols was higher amongst quarters assigned to the Selective (199/233; 85.4%) compared with the Blanket (171/249; 68.7%) group (p<0.001), and varied between farms from 64-94%. The overall agreement between results from on-farm and laboratory culture was 188/331 (56.9%; kappa=0.31; p<0.001), but varied between farms from 44.7-88.2% (p<0.001). CONCLUSIONS Use of on-farm culture with selective antimicrobial therapy resulted in approximately 25% lower antimicrobial usage, but was not associated with an increase in the proportion of cows retreated for clinical mastitis. CLINICAL RELEVANCE This study has demonstrated that on-farm culture and selective therapy based on culture results can be implemented on-farm. However, farms varied in their implementation of both the treatment protocols and microbiology procedures. Where such systems are to be used on-farm, specific training and on-going monitoring is required.
Collapse
Affiliation(s)
- S McDougall
- a Cognosco , Anexa FVC , PO Box 21, Morrinsville , New Zealand
| | - J Niethammer
- a Cognosco , Anexa FVC , PO Box 21, Morrinsville , New Zealand
| | - E M Graham
- a Cognosco , Anexa FVC , PO Box 21, Morrinsville , New Zealand
| |
Collapse
|
23
|
Cuttance E, Mason W, McDermott J, Laven R, McDougall S, Phyn C. Calf and replacement heifer mortality from birth until weaning in pasture-based dairy herds in New Zealand. J Dairy Sci 2017; 100:8347-8357. [DOI: 10.3168/jds.2017-12793] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2017] [Accepted: 07/01/2017] [Indexed: 11/19/2022]
|
24
|
Abstract
AIMS To describe colostrum quality in spring-calving dairy herds in New Zealand, in terms of Brix, pH and total and coliform bacterial counts and to investigate associations between farm management practices and these measures of colostrum quality. METHODS In June 2015, commercial dairy farms (n=105), located in North and South Islands of New Zealand, were visited shortly after the first cows had calved, and when approximately 50% and 80% of the herd had calved (early, middle and late visits). One litre of pooled colostrum that was being fed to newborn calves was collected at each visit and used to determine Brix, pH, total bacterial and coliform counts. A survey of calf management practices was conducted with the herd manager or calf rearer after the final visit. RESULTS Of 298 pooled colostrum samples tested 29/298 (9.7%) had Brix >22%. Brix was higher on farms where calves were picked up twice daily compared with once daily (18.2 (95% CI=16.5-19.9)% vs. 15.9% (95% CI=15.2-16.6)%; p=0.012), and was lower where first milking colostrum was combined with colostrum obtained at later milkings (15.0 (95% CI=13.9-16.1)%) compared with where it was not (16.9 (95% CI=16.3-17.6)%; p=0.002). Vaccination of all cows against calf diarrhoeal pathogens was associated with increased Brix compared with no vaccination (18.1 (95% CI=16.6-19.6)% vs. 16.3 (95% CI=15.6-17.0)%; p=0.033). Mean pH of samples tested decreased from 5.97 (95% CI=5.84-6.09) to 5.58 (95% CI=5.45-5.71) for early and late-season visits, respectively (p<0.001). Of 268 samples tested, 23 (8.6%) had bacterial counts below the recommended threshold of 1.00×105 cfu/mL. Mean bacterial counts increased from 2.75 (95% CI=1.80-3.70)×108 to 4.99 (95% CI=3.95-6.03)×108 cfu/mL for early and late-season visits, respectively (p<0.001). Of 259 samples tested, 23 (8.9%) had coliform counts below the recommended threshold of 1.00×104 cfu/mL. CONCLUSIONS AND CLINICAL RELEVANCE On a large majority of dairy farms included in this study the pooled colostrum fed to newborn calves had sub-optimal Brix and excessive bacterial counts. Farm-level risk factors such as twice daily pick up of calves from the paddocks, herd vaccination and feeding pooled colostrum that did not combine colostrum obtained at later milkings with first milking colostrum were associated with colostrum quality measures.
Collapse
Affiliation(s)
- K S Denholm
- a Anexa FVC , 1126 Gordonton Road, Gordonton , New Zealand
| | - J C Hunnam
- b Cognosco , 25 Moorhouse Street, Morrinsville , New Zealand
| | - E L Cuttance
- c VetEnt , 49 Benson Road, Te Awamutu 3800 , New Zealand
| | - S McDougall
- b Cognosco , 25 Moorhouse Street, Morrinsville , New Zealand
| |
Collapse
|
25
|
Affiliation(s)
- KS Denholm
- Anexa FVC, 1126 Gordonton Road, Gordonton, New Zealand
| | - JC Hunnam
- Cognosco, 25 Moorhouse Street, Morrinsville, New Zealand
| | - EL Cuttance
- VetEnt, 49 Benson Road, Te Awamutu 3800, New Zealand
| | - S McDougall
- Cognosco, 25 Moorhouse Street, Morrinsville, New Zealand
| |
Collapse
|
26
|
Abstract
Treatment with granulocyte colony-stimulating factor (G-CSF) increases polymorphonuclear cell (neutrophil) count and enhances neutrophil function in the periparturient cow. Prepartum undernutrition was hypothesized to reduce the effect of a commercially available recombinant bovine G-CSF product (pegbovigrastim) on neutrophil count and function. Hence this study was undertaken to test the effect of undernutrition for approximately 1 mo before calving on the innate immune response to pegbovigrastim. Cows (n = 99) on pasture were blocked by expected calving date and body condition score and randomly assigned in a 2 × 2 factorial design. The first factor was that cows were fed to exceed energy requirements prepartum (full feeding) or restricted to approximately 85% of prepartum energy requirements (restricted feeding). The second factor was that at approximately 7 d before expected calving date, half the cows in each feed group were injected with pegbovigrastim and the remaining half were injected with saline. Treatments were repeated on the day of calving. Blood samples were collected pre- and postcalving for complete blood count, biochemistry, and in vitro assessment of neutrophil function including phagocytosis, myeloperoxidase release, and oxidative burst. Prepartum energy restriction resulted in lower body weight, a higher proportion of cows with elevated concentrations (i.e., >0.4 mmol/L) of fatty acids, and higher average β-hydroxybutyrate concentrations before calving relative to fully fed cows. Treatment with pegbovigrastim increased the total white cell, neutrophil, lymphocyte, and monocyte counts. Pegbovigrastim treatment resulted in increased release of myeloperoxidase by neutrophils. Prepartum feeding group did not have an effect, and no feeding group × treatment interaction was observed for any of the white cell counts or functional tests. We concluded that pegbovigrastim treatment results in significant increases in neutrophil count and enhances neutrophil function as indicated by increased myeloperoxidase release. The response to pegbovigrastim was not affected by restricted prepartum energy intake.
Collapse
Affiliation(s)
- S McDougall
- Cognosco, AnexaFVC, Morrinsville, 3300, New Zealand.
| | - S J LeBlanc
- Ontario Veterinary College, University of Guelph, Guelph, ON, Canada N1G 2W1
| | - A Heiser
- AgResearch, Hopkirk Research Institute, Palmerston North, 4442, New Zealand
| |
Collapse
|
27
|
Compton CWR, Heuer C, Thomsen PT, Carpenter TE, Phyn CVC, McDougall S. Invited review: A systematic literature review and meta-analysis of mortality and culling in dairy cattle. J Dairy Sci 2016; 100:1-16. [PMID: 28341041 DOI: 10.3168/jds.2016-11302] [Citation(s) in RCA: 100] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2016] [Accepted: 09/04/2016] [Indexed: 01/21/2023]
Abstract
Dairy industries and individual farmers are concerned about mortality and culling of dairy animals. This is because the timing and fates of animals that exit dairy farms have important animal welfare and economic consequences that reflect the conditions under which they are farmed and the efficiency of their production systems. Reports from a few countries have indicated increased incidence of mortality, and occasionally culling, of dairy animals in recent decades, and these changes have been associated with intensification of production systems. Dairy industries and farmers need benchmarks for culling and mortality against which they can compare themselves, as well as improved understanding of the extent of any change and of any associated factors. We reasoned that a systematic literature review and meta-analysis of scientific articles published between 1989 and 2014 would allow us to determine whether these reports were universal, to quantify any change over time, and to investigate whether production systems or study factors were associated with culling and mortality. From 3,275 articles retrieved from databases and manual searching of cited articles, 118 articles were appraised independently by 2 assessors, and 51 articles representing 54 studies were determined to be eligible for review and meta-analysis. We estimated that both the annual incidence risk (IR) and incidence density of mortality of cows had increased significantly from 0.02 per cow and 2.32 per 100 cow-years, to 0.04 per cow and 3.75 per 100 cow-years, an increase per decade of 0.02 per cow and 1.42 per 100 cow-years, respectively. We also estimated that the annual IR of culling attributed to low production had declined significantly from 0.07 to 0.05 and that the IR of perinatal, but not neonatal, mortality had increased significantly from 0.04 to 0.06 per decade. We found no evidence of change in overall annual IR of culling of cows over time or any association between study design factors and the IR or incidence density of culling or mortality. These findings provide benchmarks for describing culling and mortality, and should encourage farmers and researchers in countries with modern dairy industries to discover and implement management strategies to reduce the animal welfare and economic costs associated with these changes.
Collapse
Affiliation(s)
- C W R Compton
- Epicentre, Institute of Vet, Animal and Biomedical Sciences, Private Bag 11 222, Massey University, Palmerston North 4442, New Zealand.
| | - C Heuer
- Epicentre, Institute of Vet, Animal and Biomedical Sciences, Private Bag 11 222, Massey University, Palmerston North 4442, New Zealand
| | - P T Thomsen
- Department of Animal Science, Aarhus University, PO Box 50, DK-8830 Tjele, Denmark
| | - T E Carpenter
- Epicentre, Institute of Vet, Animal and Biomedical Sciences, Private Bag 11 222, Massey University, Palmerston North 4442, New Zealand
| | - C V C Phyn
- DairyNZ, Private Bag 3221, Hamilton 3240, New Zealand
| | - S McDougall
- Cognosco, Anexa FVC Morrinsville, PO Box 21, Morrinsville 3340, New Zealand
| |
Collapse
|
28
|
Abstract
Do surgeons need support – and, if so, what kind?
Collapse
Affiliation(s)
- K Turner
- Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
| | | | | | | | | |
Collapse
|
29
|
Brownlie TS, Morton JM, McDougall S. Accuracy of fetal age estimates using transrectal ultrasonography for predicting calving dates in dairy cows in seasonally calving herds in New Zealand. N Z Vet J 2016; 64:324-9. [PMID: 27374055 DOI: 10.1080/00480169.2016.1207573] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
AIM To describe the accuracy of transrectal ultrasonography for predicting calving dates in dairy cows under typical New Zealand conditions and to assess potential risk factors for differences between predicted and actual calving dates. METHODS Data were collected from 116 seasonally calving herds over 2 years in a retrospective single cohort study. Transrectal ultrasonography was undertaken by experienced veterinarians (n=12) to determine if cows were pregnant, and if so to estimate fetal age. Predicted calving date was calculated by adding 282 days to the estimated conception date. Accuracy was assessed using differences between predicted and actual calving dates for each animal. Potential risk factors for animals calving >10 days before or after their predicted calving date were assessed using multinomial logistic regression models. RESULTS The study population comprised 83,104 cows over the 2 years of the study; 75,037 (90.3%) cows calved within 10 days of their predicted calving date, 3,683 (4.4%) calved >10 days earlier, and 4,384 (5.3%) >10 days later, than predicted. Risk factors for calving >10 days before or after the predicted calving date included having >1 artificial insemination (AI) before pregnancy diagnosis (p=0.03), where the cow's most recent AI was <21 days before the end of the herd's AI period (p<0.01), and where the diagnosis was made at the second or third herd-visit (p<0.01). The probability of calving being >10 days later than predicted also increased when the fetus was ≥13 weeks old at pregnancy diagnosis (p<0.01). CONCLUSIONS AND CLINICAL RELEVANCE In this study, >90% of cows diagnosed pregnant by veterinarians using transrectal ultrasonography calved within 10 days of the predicted calving date. In herds where herd reproductive performance is high, it would be expected that more cows would conceive to their first AI, and potentially fewer cows would have AI close to the end of the herd's AI period, which would increase diagnostic accuracy. Where herd managers rely on accurate predicted calving dates they should be informed about realistic expected accuracy. For greatest accuracy, a complete AI history should be made available to the person performing the pregnancy diagnoses and cows at most risk of having inaccurate predicted calving dates should be identified.
Collapse
Affiliation(s)
- T S Brownlie
- a Livestock Improvement Corporation , Private Bag 3016, Hamilton 3240 , New Zealand
| | - J M Morton
- b Jemora Pty Ltd , PO Box 2277, Geelong , Victoria 3220 , Australia
| | - S McDougall
- c Cognosco , Anexa Animal Health , PO Box 21, Morrinsville 3300 , New Zealand
| |
Collapse
|
30
|
Affiliation(s)
- S McDougall
- Cognosco, AnexaFVC, PO Box 21, Morrinsville 3340, New Zealand
| | - JE Hillerton
- DairyNZ Ltd, Private Bag No. 3221, Hamilton 3240, New Zealand
| | - D Pegram
- Fonterra Co-operative Group, Private Bag 92032, Auckland 1010, New Zealand
| |
Collapse
|
31
|
Abstract
AIMS To investigate the pathophysiology of humeral fractures in first-lactation dairy heifers in the North Island of New Zealand. METHODS Ten 2-year-old dairy heifers with humeral fractures were subject to euthanasia and the fractured and non-fractured contralateral humeri were collected. Humeri were also collected from 10 unaffected 2-year-old dairy heifers sent for slaughter. Humeri from heifers with and without fractures were examined using computed tomography (CT), and four slices of the diaphysis and lower metaphysis (D1-4) were analysed using the Bone J plug-in for Image J. The humeri were sectioned sagittally and 5 mm bone slabs were processed for histopathology. RESULTS There were no differences in bone length between the humeri from heifers with or without fractures (p=0.31). Median cortical bone mineral density at D1 was increased in humeri from affected compared with unaffected heifers (810 vs. 783 mg/cm(3); p=0.03), cortical area at D1 was reduced (816 vs. 1,037 mm(2); p=0.04), the median stress strain index, a calculated theoretical measure of bone strength, at D1 was decreased (7,288 vs. 9,072 mm(3); p<0.01), and the median ratio of overall bone volume (BV) to total volume (TV) was decreased (0.32 vs. 0.38; p<0.01). The median periosteal circumference at D1 was also reduced in humeri from affected compared with unaffected heifers (151 vs. 173 mm; p<0.01). Using a binary logistic regression model, BV/TV was the only variable associated with humeral fractures (p=0.03).In nine of 10 fractured humeri the fracture appeared to have started just distal to the head of the humerus and spiralled distally down the diaphysis to end just above the humeral condyles. Histopathological findings included a reduction in the number, and thickness, of trabeculae in the metaphysis; metaphyseal growth arrest lines, and osteoclastic resorption in fractured humeri. Concentrations of copper in serum from four of five animals with fractures were within, and one was below, normal reference ranges, while concentration of copper in the livers of three heifers with fractures were below adequate ranges. CONCLUSIONS The CT and histological findings were consistent with a diagnosis of osteoporosis. We propose that humeral fractures in dairy heifers are associated with osteoporosis, possibly as a result of insufficient deposition of bone during growth because of protein-calorie malnutrition. Increased osteoclastic resorption of bone associated with calcium mobilisation for lactation, and periods of copper deficiency may contribute to bone weakening.
Collapse
Affiliation(s)
- K E Dittmer
- a Institute of Veterinary, Animal and Biomedical Sciences , Massey University , Palmerston North , New Zealand
| | - B Hitchcock
- b Cognosco, Anexa Animal Health , Morrinsville , 3340 , New Zealand
| | - S McDougall
- b Cognosco, Anexa Animal Health , Morrinsville , 3340 , New Zealand
| | - J C Hunnam
- b Cognosco, Anexa Animal Health , Morrinsville , 3340 , New Zealand
| |
Collapse
|
32
|
McDougall S, Abbeloos E, Piepers S, Rao A, Astiz S, van Werven T, Statham J, Pérez-Villalobos N. Addition of meloxicam to the treatment of clinical mastitis improves subsequent reproductive performance. J Dairy Sci 2016; 99:2026-2042. [DOI: 10.3168/jds.2015-9615] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2015] [Accepted: 11/17/2015] [Indexed: 12/17/2022]
|
33
|
Vailati-Riboni M, Kanwal M, Bulgari O, Meier S, Priest NV, Burke CR, Kay JK, McDougall S, Mitchell MD, Walker CG, Crookenden M, Heiser A, Roche JR, Loor JJ. Body condition score and plane of nutrition prepartum affect adipose tissue transcriptome regulators of metabolism and inflammation in grazing dairy cows during the transition period. J Dairy Sci 2015; 99:758-70. [PMID: 26601585 DOI: 10.3168/jds.2015-10046] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2015] [Accepted: 09/08/2015] [Indexed: 01/11/2023]
Abstract
Recent studies demonstrating a higher incidence of metabolic disorders after calving have challenged the management practice of increasing dietary energy density during the last ~3 wk prepartum. Despite our knowledge at the whole-animal level, the tissue-level mechanisms that are altered in response to feeding management prepartum remain unclear. Our hypothesis was that prepartum body condition score (BCS), in combination with feeding management, plays a central role in the peripartum changes associated with energy balance and inflammatory state. Twenty-eight mid-lactation grazing dairy cows of mixed age and breed were randomly allocated to 1 of 4 treatment groups in a 2 × 2 factorial arrangement: 2 prepartum BCS categories (4.0 and 5.0, based on a 10-point scale; BCS4, BCS5) obtained via differential feeding management during late-lactation, and 2 levels of energy intake during the 3 wk preceding calving (75 and 125% of estimated requirements). Subcutaneous adipose tissue was harvested via biopsy at -1, 1, and 4 wk relative to parturition. Quantitative polymerase chain reaction was used to measure mRNA and microRNA (miRNA) expression of targets related to fatty acid metabolism (lipogenesis, lipolysis), adipokine synthesis, and inflammation. Both prepartum BCS and feeding management had a significant effect on mRNA and miRNA expression throughout the peripartum period. Overfed BCS5 cows had the greatest prepartum expression of fatty acid synthase (FASN) and an overall greater expression of leptin (LEP); BCS5 was also associated with greater overall adiponectin (ADIPOQ) and peroxisome proliferator-activated receptor gamma (PPARG), whereas overfeeding upregulated expression of proadipogenic miRNA. Higher postpartum expression of chemokine ligand 5 (CCL5) and the cytokines interleukin 6 (IL6) and tumor necrosis factor (TNF) was detected in overfed BCS5 cows. Feed-restricted BCS4 cows had the highest overall interleukin 1 (IL1B) expression. Prepartum feed restriction resulted in greater chemokine ligand 2 (CCL2) expression. Overall, changes in mRNA expression were consistent with the expression pattern of inflammation-related miRNA. These data shed light on molecular mechanisms underlying the effect of prepartum BCS and feeding management on metabolic and inflammatory status of adipose tissue during the peripartum period. Data support the use of a controlled feed restriction prepartum in optimally conditioned cows, as well as the use of a higher level of dietary energy in under-conditioned cows.
Collapse
Affiliation(s)
- M Vailati-Riboni
- Department of Animal Sciences, University of Illinois, Urbana 61801
| | - M Kanwal
- Department of Animal Sciences, University of Illinois, Urbana 61801
| | - O Bulgari
- Department of Animal Sciences, University of Illinois, Urbana 61801; Department of Molecular and Translational Medicine, University of Brescia, Brescia 25123, Italy
| | - S Meier
- DairyNZ Limited, Private Bag 3221, Hamilton 3240, New Zealand
| | - N V Priest
- DairyNZ Limited, Private Bag 3221, Hamilton 3240, New Zealand
| | - C R Burke
- DairyNZ Limited, Private Bag 3221, Hamilton 3240, New Zealand
| | - J K Kay
- DairyNZ Limited, Private Bag 3221, Hamilton 3240, New Zealand
| | - S McDougall
- Cognosco, Anexa Animal Health, PO Box 21, Morrinsville 3300, New Zealand
| | - M D Mitchell
- University of Queensland, Centre for Clinical Research, Royal Brisbane & Women's Hospital Campus, Herston, Queensland 4029, Australia
| | - C G Walker
- DairyNZ Limited, Private Bag 3221, Hamilton 3240, New Zealand
| | - M Crookenden
- DairyNZ Limited, Private Bag 3221, Hamilton 3240, New Zealand
| | - A Heiser
- AgResearch, Hopkirk Research Institute, Grasslands Research Centre, Palmerston North 4442, New Zealand
| | - J R Roche
- DairyNZ Limited, Private Bag 3221, Hamilton 3240, New Zealand
| | - J J Loor
- Department of Animal Sciences, University of Illinois, Urbana 61801.
| |
Collapse
|
34
|
Compton CWR, Young L, McDougall S. Efficacy of controlled-release capsules containing monensin for the prevention of subclinical ketosis in pasture-fed dairy cows. N Z Vet J 2015; 63:249-53. [PMID: 25578365 DOI: 10.1080/00480169.2014.999842] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
AIMS To determine the effectiveness of intra-rumenal controlled release capsules (CRC) containing 32 g of monensin administered pre-calving to reduce the cumulative incidence of subclinical ketosis (SCK) in mainly pasture-fed dairy cows. METHODS Cows (n=837) due to calve in the first 6 weeks of the spring calving period were enrolled from four commercial herds in the Waikato region of New Zealand in a blinded, randomised, negative-controlled field trial. Three weeks before the start of the calving period cows were randomly allocated to receive either no treatment (control) or a single CRC containing monensin and then blood sampled on two occasions, 7 days apart within 12 days following calving for measurement of concentrations of beta hydroxybutyrate (BHBA) in blood. Cows were diagnosed with SCK if the concentration of BHBA in blood in either of these samples was ≥1.2 mmol/L. RESULTS Fewer treated cows were diagnosed with SCK within 12 days post-calving than control cows (144/340 (42.4%) vs. 192/336 (57.1%); p<0.001). There was no interaction between treatment group and age, breed or herd of origin. From the final multivariable model it was estimated that treatment with CRC containing monensin reduced the absolute cumulative incidence of SCK by 17.9 (95% CI=9.2-25.8)% compared to no treatment. CONCLUSIONS Treatment with a CRC containing monensin>10 days prior to calving reduced the cumulative incidence of SCK of pasture-based dairy cows in commercial dairy herds within 12 days post-calving. CLINICAL RELEVANCE Administration pre-calving of an intra-rumenal bolus containing monensin can be considered as one of a range of management options for the control of SCK in early lactation.
Collapse
Affiliation(s)
- C W R Compton
- a Cognosco , Anexa Animal Health , PO Box 21, Morrinsville , New Zealand
| | | | | |
Collapse
|
35
|
Compton CWR, Young L, McDougall S. Subclinical ketosis in post-partum dairy cows fed a predominantly pasture-based diet: defining cut-points for diagnosis using concentrations of beta-hydroxybutyrate in blood and determining prevalence. N Z Vet J 2015; 63:241-8. [DOI: 10.1080/00480169.2014.999841] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
36
|
Vailati Riboni M, Meier S, Priest N, Burke C, Kay J, McDougall S, Mitchell M, Walker C, Crookenden M, Heiser A, Roche J, Loor J. Adipose and liver gene expression profiles in response to treatment with a nonsteroidal antiinflammatory drug after calving in grazing dairy cows. J Dairy Sci 2015; 98:3079-85. [DOI: 10.3168/jds.2014-8579] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2014] [Accepted: 01/11/2015] [Indexed: 01/16/2023]
|
37
|
Yadavilli R, Chakrabarti B, McDougall S, Horne L, Emegbo S, Craig S, Duffy N, Parker R, O'Reilly J. S25 Sleepy Snorers With "flow Limitation Syndrome": A Missed Opportunity For Cpap? Thorax 2014. [DOI: 10.1136/thoraxjnl-2014-206260.31] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
38
|
de Boer MW, Zheng T, Buddle BM, McDougall S. Detection of bovine herpesvirus type 4 antibodies and bovine lymphotropic herpesvirus in New Zealand dairy cows. N Z Vet J 2014; 62:351-5. [PMID: 24967608 DOI: 10.1080/00480169.2014.933683] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
AIM To detect the presence of bovine herpesvirus (BoHV) type 4 in New Zealand dairy cows with clinical metritis. METHODS Serum samples taken from 92 dairy cows with clinical metritis, each from a different farm, were tested for the presence of antibodies against BoHV-4 using a commercially available, indirect ELISA. Peripheral blood mononuclear cells (PBMC) were collected from 10 BoHV-4 seropositive cows, and PBMC were examined by a pan-herpesvirus nested PCR to detect herpesvirus. PCR products were sequenced directly and a proportion of the PCR products were cloned and sequenced to identify the virus present. RESULTS Antibodies to BoHV-4 were detected in 23/92 (25%) serum samples. The pan-herpesvirus PCR was positive in 8/10 PBMC samples. Cloning and sequencing identified that all of the eight PCR-positive PBMC contained bovine lymphotropic herpesvirus (BLHV); no BoHV-4 DNA was detected. CONCLUSIONS This study reports the finding of the presence of apparent antibodies to BoHV-4, and BLHV DNA in New Zealand dairy cows affected by metritis. CLINICAL RELEVANCE Bovine herpesvirus type 4 and BLHV are reported to have the potential to cause reproduction failure in cows. This is the first report of apparent BoHV-4 antibodies, and BLHV in New Zealand. The importance and epidemiology of these viruses in cattle in New Zealand requires further investigation.
Collapse
Affiliation(s)
- M W de Boer
- a Anexa Animal Health , Cognosco , PO Box 21, Morrinsville , 3300 , New Zealand
| | | | | | | |
Collapse
|
39
|
Woolf EJ, McDougall S, Fast DM, Andraus M, Barfield M, Blackburn M, Gordon B, Hoffman D, Inoue N, Marcelin-Jimenez G, Flynn A, LeLacheur R, Reuschel S, Santhanam R, Bennett P, Duncan B, Hayes R, Lausecker B, Sharma A, Togashi K, Trivedi RK, Vago M, White S, Barton H, Dunn JA, Farmen RH, Heinig K, Holliman C, Komaba J, Riccio MF, Thomas E. Small molecule specific run acceptance, specific assay operation, and chromatographic run quality assessment: recommendation for best practices and harmonization from the global bioanalysis consortium harmonization teams. AAPS J 2014; 16:885-93. [PMID: 24961918 DOI: 10.1208/s12248-014-9633-4] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/30/2014] [Accepted: 05/30/2014] [Indexed: 11/30/2022]
Abstract
Consensus practices and regulatory guidance for liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) assays of small molecules are more aligned globally than for any of the other bioanalytical techniques addressed by the Global Bioanalysis Consortium. The three Global Bioanalysis Consortium Harmonization Teams provide recommendations and best practices for areas not yet addressed fully by guidances and consensus for small molecule bioanalysis. Recommendations from all three teams are combined in this report for chromatographic run quality, validation, and sample analysis run acceptance.
Collapse
Affiliation(s)
- Eric J Woolf
- Merck Research Laboratories, WP 75B-300, West Point, Pennsylvania, 19486, USA,
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
de Boer MW, LeBlanc SJ, Dubuc J, Meier S, Heuwieser W, Arlt S, Gilbert RO, McDougall S. Invited review: Systematic review of diagnostic tests for reproductive-tract infection and inflammation in dairy cows. J Dairy Sci 2014; 97:3983-99. [PMID: 24835959 DOI: 10.3168/jds.2013-7450] [Citation(s) in RCA: 73] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2013] [Accepted: 03/29/2014] [Indexed: 11/19/2022]
Abstract
The objective of this study was to conduct a systematic and critical appraisal of the quality of previous publications and describe diagnostic methods, diagnostic criteria and definitions, repeatability, and agreement among methods for diagnosis of vaginitis, cervicitis, endometritis, salpingitis, and oophoritis in dairy cows. Publications (n=1,600) that included the words "dairy," "cows," and at least one disease of interest were located with online search engines. In total, 51 papers were selected for comprehensive review by pairs of the authors. Only 61% (n=31) of the 51 reviewed papers provided a definition or citation for the disease or diagnostic methods studied, and only 49% (n=25) of the papers provided the data or a citation to support the test cut point used for diagnosing disease. Furthermore, a large proportion of the papers did not provide sufficient detail to allow critical assessment of the quality of design or reporting. Of 11 described diagnostic methods, only one complete methodology, i.e., vaginoscopy, was assessed for both within- and between-operator repeatability (κ=0.55-0.60 and 0.44, respectively). In the absence of a gold standard, comparisons between different tests have been undertaken. Agreement between the various diagnostic methods is at a low level. These discrepancies may indicate that these diagnostic methods assess different aspects of reproductive health and underline the importance of tying diagnostic criteria to objective measures of reproductive performance. Those studies that used a reproductive outcome to select cut points and tests have the greatest clinical utility. This approach has demonstrated, for example, that presence of (muco)purulent discharge in the vagina and an increased proportion of leukocytes in cytological preparations following uterine lavage or cytobrush sampling are associated with poorer reproductive outcomes. The lack of validated, consistent definitions and outcome variables makes comparisons of the different tests difficult. The quality of design and reporting in future publications could be improved by using checklists as a guideline. Further high-quality research based on published standards to improve study design and reporting should improve cow-side diagnostic tests. Specifically, more data on intra- and interobserver agreement are needed to evaluate test variability. Also, more studies are necessary to determine optimal cut points and time postpartum of examination.
Collapse
Affiliation(s)
- M W de Boer
- Cognosco, Anexa Animal Health, Morrinsville 3300, New Zealand; Epicentre, Institute of Veterinary, Animal and Biomedical Sciences, Massey University, Palmerston North 4442, New Zealand.
| | - S J LeBlanc
- Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1, Canada
| | - J Dubuc
- Département de Sciences Cliniques, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec J2S 7C6, Canada
| | - S Meier
- DairyNZ Limited, Hamilton 3240, New Zealand
| | - W Heuwieser
- Clinic for Animal Reproduction, Faculty of Veterinary Medicine, Freie Universität Berlin, 14163 Berlin, Germany
| | - S Arlt
- Clinic for Animal Reproduction, Faculty of Veterinary Medicine, Freie Universität Berlin, 14163 Berlin, Germany
| | - R O Gilbert
- Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853
| | - S McDougall
- Cognosco, Anexa Animal Health, Morrinsville 3300, New Zealand
| |
Collapse
|
41
|
Compton CWR, Emslie FR, McDougall S. Randomised controlled trials demonstrate efficacy of a novel internal teat sealant to prevent new intramammary infections in dairy cows and heifers. N Z Vet J 2014; 62:258-66. [DOI: 10.1080/00480169.2014.898201] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
42
|
Meier S, Priest N, Burke C, Kay J, McDougall S, Mitchell M, Walker C, Heiser A, Loor J, Roche J. Treatment with a nonsteroidal antiinflammatory drug after calving did not improve milk production, health, or reproduction parameters in pasture-grazed dairy cows. J Dairy Sci 2014; 97:2932-43. [DOI: 10.3168/jds.2013-7838] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2013] [Accepted: 02/08/2014] [Indexed: 11/19/2022]
|
43
|
|
44
|
Brownlie TS, Morton JM, Heuer C, Hunnam J, McDougall S. Reproductive performance of seasonal-calving, pasture-based dairy herds in four regions of New Zealand. N Z Vet J 2013; 62:77-86. [PMID: 24256438 DOI: 10.1080/00480169.2013.848499] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
AIMS The primary objective of this study was to describe the reproductive performance of a selection of New Zealand dairy herds in 2009/10 and 2010/11. A secondary objective was to explore associations between a number of biophysical and socio-demographic herd-level variables and herd-level reproductive outcomes. METHODS Seasonal-calving, pasture-based herds from the Waikato (n=16), Taranaki (n=16), North Canterbury (n=17) and South Canterbury (n=14) regions of New Zealand were enrolled as part of a larger study. Submission, conception and pregnancy risks ("in-calf risks") were calculated for 2009/10 and 2010/11 based on cow-level records and from the results of strategically timed pregnancy diagnoses. Additional herd-level information was collected during interviews with the herd key decision maker (KDM). Associations between independent variables and reproductive performance were examined using univariable and multivariable generalised linear models. RESULTS Mean 6-week in-calf risk of the herds over both study years was 67 (min 46, max 86)%, mean 3-week submission risk was 81 (min 44, max 95)% and mean probability of pregnancy at first insemination was 48 (min 25, max 71)%. On univariable analyses, the herd's 6-week in-calf risk in the year before enrollment (2008/09) was the strongest identified predictor of each of submission risk, probability of pregnancy at first insemination and 6-week in-calf risk (all p<0.01), while other predictor variables considered were non-significant. From multivariable modelling, herds using extensive production systems had better reproductive performance than more intensively managed systems. Higher 3-week submission risks were achieved in herds where the KDM were farm managers rather than owner operators, and where the predominant breed was Jersey rather than Friesian. CONCLUSIONS The New Zealand dairy industry has set a target for a mean 6-week in-calf risk of 78%, with minimal hormonal intervention, by 2016. Achieving this target appears unlikely unless there are substantial increases in both submission risks and pregnancy at first inseminations. The mean 6-week in-calf risk of New Zealand dairy herd does not appear to have changed in the last decade. However the large differences between herds indicate that better reproductive performance is currently possible in many herds. The herd's 6-week in-calf risk in the year before enrollment (2008/09) was the strongest identified predictor of current 6-week in-calf risk, suggesting that rate of improvement in reproductive performance would be slow within current management systems unless substantial changes are introduced.
Collapse
Affiliation(s)
- T S Brownlie
- a Cognosco, Anexa Animal Health , Morrinsville , New Zealand
| | | | | | | | | |
Collapse
|
45
|
McDougall S, Hussein H, Petrovski K. Antimicrobial resistance in Staphylococcus aureus, Streptococcus uberis and Streptococcus dysgalactiae from dairy cows with mastitis. N Z Vet J 2013; 62:68-76. [PMID: 24215609 DOI: 10.1080/00480169.2013.843135] [Citation(s) in RCA: 48] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
AIMS To determine the minimal inhibitory concentrations (MIC) of antimicrobials for common mastitis pathogens from dairy cows in New Zealand; and to assess the effect of source of the isolates, i.e. commercial veterinary laboratories or collected as part of research studies; the clinical status of the cow, i.e. subclinical or clinical mastitis; cow age and herd on the distribution of the MIC. METHODS Minimal inhibitory concentrations for Staphylococcus aureus (n=364), Streptococcus dysgalactiae (n=65) and Streptococcus uberis (n=102) isolated from milk samples from dairy cows were determined for a variety of antimicrobials using broth microdilution. Isolates of S. aureus were sourced from research studies from both subclinically (n=161) and clinically (n=104) affected cows, as well as from commercial veterinary laboratories (n=101); while all the streptococcal isolates were from commercial laboratories. Resistance was defined using the cut-points provided by the Clinical and Laboratory Standards Institute (CLSI). RESULTS The distribution of MIC varied among the bacterial species for every antimicrobial tested (p<0.001). Of the S. aureus isolates, 28, 2 and 0.5% were resistant to penicillin, ampicillin and trimethoprim/sulfamethoxazole, respectively. For S. dysgalactiae and S. uberis isolates, 17 and 13% were resistant to trimethoprim/sulfamethoxazole, respectively. One isolate (1%) of S. uberis was resistant to penicillin. The distribution of MIC of S. aureus varied with clinical status, between herds, and with age of cow (p<0.05). The distribution of MIC for S. aureus for penicillin, amoxicillin/clavulanic acid, cloxacillin and ampicillin were lower from clinical than subclinical cases, and those for amoxicillin/clavulanic acid and oxytetracycline from isolates from veterinary laboratories were lower than for those from research studies. CONCLUSIONS Resistance to some beta-lactam antimicrobials and trimethoprim/sulfamethoxazole were found in isolates from cases of bovine mastitis. The distribution of MIC for isolates of S. aureus varied with clinical status of the cow, the age of the cow, the herd and with the source of isolate. CLINICAL SIGNIFICANCE Resistance to penicillin was found in a quarter of S. aureus isolates, but in virtually no Streptococcus isolates; therefore microbial identification and sensitivity testing would be beneficial when assessing treatment options. The source of the isolates affected the estimated MIC, suggesting that selection of isolates for monitoring of resistance requires care and that use of routine submissions to commercial laboratories to assess antimicrobial resistance patterns may result in biased estimates of prevalence of resistance.
Collapse
Affiliation(s)
- S McDougall
- a Cognosco, Anexa Animal Health , PO Box 21, Morrinsville , New Zealand
| | | | | |
Collapse
|
46
|
Steele N, McDougall S. Effect of prolonged duration therapy of subclinical mastitis in lactating dairy cows using penethamate hydriodide. N Z Vet J 2013; 62:38-46. [DOI: 10.1080/00480169.2013.830350] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
47
|
Weir A, Heuer C, McDougall S, Voges H. Use of an enzyme-linked immunosorbent assay for detecting bovine viral diarrhoea virus antibodies in individual cow milk samples. N Z Vet J 2013; 61:305-9. [DOI: 10.1080/00480169.2012.757729] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
48
|
Compton CWR, McDougall S, Young L, Bryan MA. Prevalence of subclinical ketosis in mainly pasture-grazed dairy cows in New Zealand in early lactation. N Z Vet J 2013; 62:30-7. [DOI: 10.1080/00480169.2013.823829] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
49
|
Priest N, McDougall S, Burke C, Roche J, Mitchell M, McLeod K, Greenwood S, Meier S. The responsiveness of subclinical endometritis to a nonsteroidal antiinflammatory drug in pasture-grazed dairy cows. J Dairy Sci 2013; 96:4323-32. [DOI: 10.3168/jds.2012-6266] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2012] [Accepted: 03/15/2013] [Indexed: 11/19/2022]
|
50
|
De Vliegher S, Fox LK, Piepers S, McDougall S, Barkema HW. Invited review: Mastitis in dairy heifers: nature of the disease, potential impact, prevention, and control. J Dairy Sci 2012; 95:1025-40. [PMID: 22365187 DOI: 10.3168/jds.2010-4074] [Citation(s) in RCA: 279] [Impact Index Per Article: 23.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2010] [Accepted: 11/16/2011] [Indexed: 01/09/2023]
Abstract
Heifer mastitis is a disease that potentially threatens production and udder health in the first and subsequent lactations. In general, coagulase-negative staphylococci (CNS) are the predominant cause of intramammary infection and subclinical mastitis in heifers around parturition, whereas Staphylococcus aureus and environmental pathogens cause a minority of the cases. Clinical heifer mastitis is typically caused by the major pathogens. The variation in proportions of causative pathogens between studies, herds, and countries is considerable. The magnitude of the effect of heifer mastitis on an individual animal is influenced by the form of mastitis (clinical versus subclinical), the virulence of the causative pathogen(s) (major versus minor pathogens), the time of onset of infection relative to calving, cure or persistence of the infection when milk production has started, and the host's immunity. Intramammary infection in early lactation caused by CNS does not generally have a negative effect on subsequent productivity. At the herd level, the impact will depend on the prevalence and incidence of the disease, the nature of the problem (clinical, subclinical, nonfunctional quarters), the causative pathogens involved (major versus minor pathogens), the ability of the animals to cope with the disease, and the response of the dairy manager to control the disease through management changes. Specific recommendations to prevent and control mastitis in late gestation in periparturient heifers are not part of the current National Mastitis Council mastitis and prevention program. Control and prevention is currently based on avoidance of inter-sucking among young stock, fly control, optimal nutrition, and implementation of hygiene control and comfort measures, especially around calving. More risk factors for subclinical and clinical heifer mastitis have been identified (e.g., season, location of herd, stage of pregnancy) although they do not lend themselves to the development of specific intervention strategies designed to prevent the disease. Pathogen-specific risk factors and associated control measures need to be identified due to the pathogen-related variation in epidemiology and effect on future performance. Prepartum intramammary treatment with antibiotics has been proposed as a simple and effective way of controlling heifer mastitis but positive long-lasting effects on somatic cell count and milk yield do not always occur, ruling out universal recommendation of this practice. Moreover, use of antibiotics in this manner is off-label and results in an increased risk of antibiotic residues in milk. Prepartum treatment can be implemented only as a short-term measure to assist in the control of a significant heifer mastitis problem under supervision of the herd veterinarian. When CNS are the major cause of intramammary infection in heifers, productivity is not affected, making prepartum treatment redundant and even unwanted. In conclusion, heifer mastitis can affect the profitability of dairy farming because of a potential long-term negative effect on udder health and milk production and an associated culling risk, specifically when major pathogens are involved. Prevention and control is not easy but is possible through changes in young stock and heifer management. However, the pathogenesis and epidemiology of the disease remain largely unknown and more pathogen-specific risk factors should be identified to optimize current prevention programs.
Collapse
Affiliation(s)
- S De Vliegher
- M-team and Mastitis and Milk Quality Research Unit, Department of Reproduction, Obstetrics and Herd Health, Faculty of Veterinary Medicine, Ghent University, Merelbeke 9820, Belgium.
| | | | | | | | | |
Collapse
|